TGThaís Galarraga

Thaís Galarraga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thaís Galarraga has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Bruna Pontin

    Institute of Cardiology, University Cardiology Foundation - IC/FUC, Avenida Princesa Isabel, 370/ 3 andar., Porto Alegre, Rio Grande do Sul, 90620-000, Brazil

    1 shared publication
  • Denise Zaffari

    Institute of Cardiology, University Cardiology Foundation - IC/FUC, Avenida Princesa Isabel, 370/ 3 andar., Porto Alegre, Rio Grande do Sul, 90620-000, Brazil

    1 shared publication
  • Grasiele Sausen

    Institute of Cardiology, University Cardiology Foundation - IC/FUC, Avenida Princesa Isabel, 370/ 3 andar., Porto Alegre, Rio Grande do Sul, 90620-000, Brazil

    1 shared publication
  • Guilherme Balsan

    Institute of Cardiology, University Cardiology Foundation - IC/FUC, Avenida Princesa Isabel, 370/ 3 andar., Porto Alegre, Rio Grande do Sul, 90620-000, Brazil

    1 shared publication
  • Lucia Campos Pellanda

    Fundação Universidade Federal de Ciências da Saúde de Porto Alegre

    1 shared publication
  • Vera Lúcia Portal

    Graduate Program in Health Sciences (Cardiology), Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology (IC/FUC), Princesa Isabel Avenue, 395, Porto Alegre, Rio Grande do Sul 90040-371, Brazil

    1 shared publication

Latest Publications

  • Open Access

    Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial

    by Guilherme Balsan, Lúcia Campos Pellanda, Grasiele Sausen, Thaís Galarraga, Denise Zaffari, Bruna Pontin, Vera Lúcia Portal

    This study aimed to evaluate the effect of the intake of yerba mate (YM) and green tea (GT) on serum levels of leptin and paraoxonase-1 (PON-1), compared to control. Controlled, randomized clinical trial (RCT) that evaluated 142 men and women affected by overweight or obesity aged 35–60 years, untreated dyslipidemia and no history of coronary artery disease. Participants were randomized to ingest 1000 mL GT, YM or apple tea (AT, control group) daily, during eight weeks. Serum PON-1 and leptin levels were analyzed by ELISA immunoassay at the beginning (baseline) and after eight weeks of intervention. The intake of 1 l of YM/day resulted in significant increase in serum levels of PON-1 (9.7%; p = 0.005). The consumption of GT induced no significant difference in the levels of PON-1 (p = 0.154) and leptin (p = 0.783). Intergroup analysis showed a significant difference (p = 0.036) in the variation of PON-1 levels in the YM group when compared to GT and AT groups. In addition, the increase in PON-1 levels in the YM group was significantly associated with increased HDL-c (p = 0.004). The intake of yerba mate increased the antioxidant capacity by increasing serum levels of PON-1 and was positively associated with increased HDL-c, stressing the protective role of this beverage against atherosclerotic diseases. GT intake had no significant effect on serum levels of PON-1 and leptin. This study is registered with ClinicalTrials.gov under protocol number NCT00933647.